Health
J&J COVID-19 vaccine is 72% effective in the U.S., and 66% overall in large trial – Reuters
Johnson & Johnson said on Friday that its single-dose vaccine was 66% effective in preventing COVID-19 in a large global trial against multiple variants which will…
(Reuters) – Johnson & Johnson said on Friday that its single-dose vaccine was 66% effective in preventing COVID-19 in a large global trial against multiple variants which will give health officials another weapon to tackle the coronavirus.
FILE PHOTO: A vial and sryinge are seen in front of a displayed Johnson&Johnson logo in this illustration taken January 11, 2021. REUTERS/Dado Ruvic
In the trial of nearly 44,000 volunteers, the level of protection against moderate and severe COVID-19 varied from…
-
Noosa News21 hours agoWoman charged with murder after child found dead inside Bundaberg home
-
Noosa News19 hours agoNew Partner, Special Counsel appointed – Proctor
-
General22 hours agoQueensland LNP government spends millions on ads to spruik own policies
-
Noosa News17 hours agoMan arrested in Gold Coast after cyclist critical in alleged hit-and-run